The Bamlanivimab+Etesevimab are anti-SARC-COVID-2 monoclonal antibodies which have received Emergency Use Authorization (EUA) from US FDA as well as conditional use approval from the MoHP, Department of Drug Administration (DDA) …
Tag:
Protocol
- National Plan, Policy & GuidelinesPublic HealthResearch & Publication
Rehabilitation Clinical Protocol on: Osteoarthritis of Knee, Non-Specific Back Pain, Stroke, Developmental Delay and Cerebral Palsy
Overview The Epidemiology and Disease Control Division (EDCD) has released a new protocol for rehabilitative services. The Rehabilitation Clinical Protocol consists of guidance on Osteoarthritis of Knee, Non-Specific Back Pain, …
